Japan Urology Drugs Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Urology Drugs market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Urology Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Urology Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Astellas

    • Endo

    • Tolmar

    • GP Pharm

    By Type:

    • ? (alpha)-blockers

    • 5 ?-reductase inhibitors

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Urology Drugs Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Urology Drugs Market Size and Growth Rate of ? (alpha)-blockers from 2014 to 2026

      • 1.3.2 Japan Urology Drugs Market Size and Growth Rate of 5 ?-reductase inhibitors from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Urology Drugs Market Size and Growth Rate of Hospital from 2014 to 2026

      • 1.4.2 Japan Urology Drugs Market Size and Growth Rate of Clinic from 2014 to 2026

      • 1.4.3 Japan Urology Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Urology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Urology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Urology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Urology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Urology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Urology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Urology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Urology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Urology Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Urology Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of ? (alpha)-blockers

      • 3.4.2 Market Size and Growth Rate of 5 ?-reductase inhibitors

    4 Segmentation of Urology Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Urology Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Urology Drugs in Hospital

      • 4.4.2 Market Size and Growth Rate of Urology Drugs in Clinic

      • 4.4.3 Market Size and Growth Rate of Urology Drugs in Others

    5 Market Analysis by Regions

    • 5.1 Japan Urology Drugs Production Analysis by Regions

    • 5.2 Japan Urology Drugs Consumption Analysis by Regions

    6 Hokkaido Urology Drugs Landscape Analysis

    • 6.1 Hokkaido Urology Drugs Landscape Analysis by Major Types

    • 6.2 Hokkaido Urology Drugs Landscape Analysis by Major End-Users

    7 Tohoku Urology Drugs Landscape Analysis

    • 7.1 Tohoku Urology Drugs Landscape Analysis by Major Types

    • 7.2 Tohoku Urology Drugs Landscape Analysis by Major End-Users

    8 Kanto Urology Drugs Landscape Analysis

    • 8.1 Kanto Urology Drugs Landscape Analysis by Major Types

    • 8.2 Kanto Urology Drugs Landscape Analysis by Major End-Users

    9 Chubu Urology Drugs Landscape Analysis

    • 9.1 Chubu Urology Drugs Landscape Analysis by Major Types

    • 9.2 Chubu Urology Drugs Landscape Analysis by Major End-Users

    10 Kinki Urology Drugs Landscape Analysis

    • 10.1 Kinki Urology Drugs Landscape Analysis by Major Types

    • 10.2 Kinki Urology Drugs Landscape Analysis by Major End-Users

    11 Chugoku Urology Drugs Landscape Analysis

    • 11.1 Chugoku Urology Drugs Landscape Analysis by Major Types

    • 11.2 Chugoku Urology Drugs Landscape Analysis by Major End-Users

    12 Shikoku Urology Drugs Landscape Analysis

    • 12.1 Shikoku Urology Drugs Landscape Analysis by Major Types

    • 12.2 Shikoku Urology Drugs Landscape Analysis by Major End-Users

    13 Kyushu Urology Drugs Landscape Analysis

    • 13.1 Kyushu Urology Drugs Landscape Analysis by Major Types

    • 13.2 Kyushu Urology Drugs Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Astellas

      • 14.1.1 Astellas Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Endo

      • 14.2.1 Endo Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Tolmar

      • 14.3.1 Tolmar Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 GP Pharm

      • 14.4.1 GP Pharm Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 117 Figures and 169 Tables)

    • Figure Japan Urology Drugs Market Size and Growth Rate of ? (alpha)-blockers from 2014 to 2026

    • Figure Japan Urology Drugs Market Size and Growth Rate of 5 ?-reductase inhibitors from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Urology Drugs Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Japan Urology Drugs Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure Japan Urology Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Urology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Urology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Urology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Urology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Urology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Urology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Urology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Urology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Urology Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Urology Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Urology Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Urology Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of ? (alpha)-blockers

    • Figure Market Size and Growth Rate of 5 ?-reductase inhibitors

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Urology Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Urology Drugs by Different End-Users from 2014 to 2026

    • Figure Japan Urology Drugs Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Japan Urology Drugs Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure Japan Urology Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan Urology Drugs Production by Regions

    • Table Japan Urology Drugs Production Share by Regions

    • Figure Japan Urology Drugs Production Share by Regions in 2014

    • Figure Japan Urology Drugs Production Share by Regions in 2018

    • Figure Japan Urology Drugs Production Share by Regions in 2026

    • Table Japan Urology Drugs Consumption by Regions

    • Table Japan Urology Drugs Consumption Share by Regions

    • Figure Japan Urology Drugs Consumption Share by Regions in 2014

    • Figure Japan Urology Drugs Consumption Share by Regions in 2018

    • Figure Japan Urology Drugs Consumption Share by Regions in 2026

    • Table Hokkaido Urology Drugs Consumption by Types from 2014 to 2026

    • Table Hokkaido Urology Drugs Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Urology Drugs Consumption Share by Types in 2014

    • Figure Hokkaido Urology Drugs Consumption Share by Types in 2018

    • Figure Hokkaido Urology Drugs Consumption Share by Types in 2026

    • Table Hokkaido Urology Drugs Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Urology Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Urology Drugs Consumption Share by End-Users in 2014

    • Figure Hokkaido Urology Drugs Consumption Share by End-Users in 2018

    • Figure Hokkaido Urology Drugs Consumption Share by End-Users in 2026

    • Table Tohoku Urology Drugs Consumption by Types from 2014 to 2026

    • Table Tohoku Urology Drugs Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Urology Drugs Consumption Share by Types in 2014

    • Figure Tohoku Urology Drugs Consumption Share by Types in 2018

    • Figure Tohoku Urology Drugs Consumption Share by Types in 2026

    • Table Tohoku Urology Drugs Consumption by End-Users from 2014 to 2026

    • Table Tohoku Urology Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Urology Drugs Consumption Share by End-Users in 2014

    • Figure Tohoku Urology Drugs Consumption Share by End-Users in 2018

    • Figure Tohoku Urology Drugs Consumption Share by End-Users in 2026

    • Table Kanto Urology Drugs Consumption by Types from 2014 to 2026

    • Table Kanto Urology Drugs Consumption Share by Types from 2014 to 2026

    • Figure Kanto Urology Drugs Consumption Share by Types in 2014

    • Figure Kanto Urology Drugs Consumption Share by Types in 2018

    • Figure Kanto Urology Drugs Consumption Share by Types in 2026

    • Table Kanto Urology Drugs Consumption by End-Users from 2014 to 2026

    • Table Kanto Urology Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Urology Drugs Consumption Share by End-Users in 2014

    • Figure Kanto Urology Drugs Consumption Share by End-Users in 2018

    • Figure Kanto Urology Drugs Consumption Share by End-Users in 2026

    • Table Chubu Urology Drugs Consumption by Types from 2014 to 2026

    • Table Chubu Urology Drugs Consumption Share by Types from 2014 to 2026

    • Figure Chubu Urology Drugs Consumption Share by Types in 2014

    • Figure Chubu Urology Drugs Consumption Share by Types in 2018

    • Figure Chubu Urology Drugs Consumption Share by Types in 2026

    • Table Chubu Urology Drugs Consumption by End-Users from 2014 to 2026

    • Table Chubu Urology Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Urology Drugs Consumption Share by End-Users in 2014

    • Figure Chubu Urology Drugs Consumption Share by End-Users in 2018

    • Figure Chubu Urology Drugs Consumption Share by End-Users in 2026

    • Table Kinki Urology Drugs Consumption by Types from 2014 to 2026

    • Table Kinki Urology Drugs Consumption Share by Types from 2014 to 2026

    • Figure Kinki Urology Drugs Consumption Share by Types in 2014

    • Figure Kinki Urology Drugs Consumption Share by Types in 2018

    • Figure Kinki Urology Drugs Consumption Share by Types in 2026

    • Table Kinki Urology Drugs Consumption by End-Users from 2014 to 2026

    • Table Kinki Urology Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Urology Drugs Consumption Share by End-Users in 2014

    • Figure Kinki Urology Drugs Consumption Share by End-Users in 2018

    • Figure Kinki Urology Drugs Consumption Share by End-Users in 2026

    • Table Chugoku Urology Drugs Consumption by Types from 2014 to 2026

    • Table Chugoku Urology Drugs Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Urology Drugs Consumption Share by Types in 2014

    • Figure Chugoku Urology Drugs Consumption Share by Types in 2018

    • Figure Chugoku Urology Drugs Consumption Share by Types in 2026

    • Table Chugoku Urology Drugs Consumption by End-Users from 2014 to 2026

    • Table Chugoku Urology Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Urology Drugs Consumption Share by End-Users in 2014

    • Figure Chugoku Urology Drugs Consumption Share by End-Users in 2018

    • Figure Chugoku Urology Drugs Consumption Share by End-Users in 2026

    • Table Shikoku Urology Drugs Consumption by Types from 2014 to 2026

    • Table Shikoku Urology Drugs Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Urology Drugs Consumption Share by Types in 2014

    • Figure Shikoku Urology Drugs Consumption Share by Types in 2018

    • Figure Shikoku Urology Drugs Consumption Share by Types in 2026

    • Table Shikoku Urology Drugs Consumption by End-Users from 2014 to 2026

    • Table Shikoku Urology Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Urology Drugs Consumption Share by End-Users in 2014

    • Figure Shikoku Urology Drugs Consumption Share by End-Users in 2018

    • Figure Shikoku Urology Drugs Consumption Share by End-Users in 2026

    • Table Kyushu Urology Drugs Consumption by Types from 2014 to 2026

    • Table Kyushu Urology Drugs Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Urology Drugs Consumption Share by Types in 2014

    • Figure Kyushu Urology Drugs Consumption Share by Types in 2018

    • Figure Kyushu Urology Drugs Consumption Share by Types in 2026

    • Table Kyushu Urology Drugs Consumption by End-Users from 2014 to 2026

    • Table Kyushu Urology Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Urology Drugs Consumption Share by End-Users in 2014

    • Figure Kyushu Urology Drugs Consumption Share by End-Users in 2018

    • Figure Kyushu Urology Drugs Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Astellas

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas

    • Figure Sales and Growth Rate Analysis of Astellas

    • Figure Revenue and Market Share Analysis of Astellas

    • Table Product and Service Introduction of Astellas

    • Table Company Profile and Development Status of Endo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo

    • Figure Sales and Growth Rate Analysis of Endo

    • Figure Revenue and Market Share Analysis of Endo

    • Table Product and Service Introduction of Endo

    • Table Company Profile and Development Status of Tolmar

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tolmar

    • Figure Sales and Growth Rate Analysis of Tolmar

    • Figure Revenue and Market Share Analysis of Tolmar

    • Table Product and Service Introduction of Tolmar

    • Table Company Profile and Development Status of GP Pharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GP Pharm

    • Figure Sales and Growth Rate Analysis of GP Pharm

    • Figure Revenue and Market Share Analysis of GP Pharm

    • Table Product and Service Introduction of GP Pharm

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.